Literature DB >> 23020942

Comorbidities of bladder pain syndrome/interstitial cystitis: a population-based study.

Joseph J Keller1, Yi-Kuang Chen, Herng-Ching Lin.   

Abstract

UNLABELLED: Study Type--System prevalence (cohort) Level of Evidence 2a. What's known on the subject? and What does the study add? Compared with the general population, patients with BPS/IC often experience difficulties in performing normal activities owing to physical limitations, decreased energy, greater pain and impaired social functioning With the exception of metastatic cancer, separate conditional logistic regression analyses in this study suggested that subjects with BPS/IC were consistently more likely than subjects without BPS/IC to have all the medical comorbidities investigated. When compared with subjects without BPS/IC, subjects with BPS/IC had particularly higher odds of comorbid neurological diseases, rheumatological diseases and mental illnesses.
OBJECTIVE: • To explore the comorbid medical conditions of patients with bladder pain syndrome/interstitial cystitis (BPS/IC) in Taiwan using a cross-sectional study design and a population-based administrative database. SUBJECTS AND METHODS: • The study included 9269 subjects with BPS/IC and 46,345 randomly selected comparison subjects. • Conditional logistic regression analyses were performed to calculate the odds ratio for each of the 32 medical comorbidities (hypertension, congestive heart failure, cardiac arrhythmias, blood loss anaemia, peripheral vascular disorders, stroke, ischaemic heart disease, hyperlipidaemia, hepatitis B or C, migraines, headaches, Parkinson's disease, rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, pulmonary circulation disorders, chronic pulmonary disease, diabetes, hypothyroidism, renal failure, fluid and electrolyte disorders, liver diseases, peptic ulcers, deficiency anaemias, depressive disorder, psychoses, metastatic cancer, solid tumour without metastasis, alcohol abuse, drug abuse and asthma) between subjects with and without BPS/IC.
RESULTS: • With the exception of metastatic cancer, the subjects with BPS/IC had a significantly higher prevalence of all the medical comorbidities analysed than subjects without BPS/IC. • With the exception of metastatic cancer, separate conditional logistic regression analyses suggested that subjects with BPS/IC were consistently more likely than subjects without BPS/IC to have any of the medical comorbidities investigated in this study. • When compared with subjects without BPS/IC, subjects with BPS/IC had particularly higher odds of comorbid neurological diseases, rheumatological diseases and mental illnesses.
CONCLUSION: • Our results indicated that subjects with BPS/IC had an increased prevalence of multiple comorbidities.
© 2012 THE AUTHORS. BJU INTERNATIONAL © 2012 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2012        PMID: 23020942     DOI: 10.1111/j.1464-410X.2012.11539.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  14 in total

1.  When Is a Disease a "Disease"?

Authors:  Jeffrey Bland
Journal:  Integr Med (Encinitas)       Date:  2015-12

2.  Risk of associated conditions in relatives of subjects with interstitial cystitis.

Authors:  Kristina Allen-Brady; Peggy A Norton; Lisa Cannon-Albright
Journal:  Female Pelvic Med Reconstr Surg       Date:  2015 Mar-Apr       Impact factor: 2.091

3.  Increased risks of healthcare-seeking behaviors of anxiety, depression and insomnia among patients with bladder pain syndrome/interstitial cystitis: a nationwide population-based study.

Authors:  Yao-Chi Chuang; Shih-Feng Weng; Ya-Wen Hsu; Charles Lung-Cheng Huang; Ming-Ping Wu
Journal:  Int Urol Nephrol       Date:  2015-01-11       Impact factor: 2.370

4.  A bibliometric analysis of top-cited journal articles in interstitial cystitis and bladder pain syndrome.

Authors:  Xing-Peng Di; Liao Peng; Li-Yuan Xiang; Meng-Hua Wang; Jie Zhang; De-Yi Luo
Journal:  Int Urogynecol J       Date:  2022-07-26       Impact factor: 1.932

Review 5.  Deciphering microRNA code in pain and inflammation: lessons from bladder pain syndrome.

Authors:  Ali Hashemi Gheinani; Fiona C Burkhard; Katia Monastyrskaya
Journal:  Cell Mol Life Sci       Date:  2013-03-05       Impact factor: 9.261

6.  Comorbidities in a Nationwide, Heterogenous Population of Veterans with Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  Bethany F Laden; Catherine Bresee; Amanda De Hoedt; Kai B Dallas; April Scharfenberg; Roopali Saxena; Justin F Senechal; Kamil E Barbour; Jayoung Kim; Stephen J Freedland; Jennifer T Anger
Journal:  Urology       Date:  2021-04-23       Impact factor: 2.649

Review 7.  Pathomechanism of Interstitial Cystitis/Bladder Pain Syndrome and Mapping the Heterogeneity of Disease.

Authors:  Jia-Fong Jhang; Hann-Chorng Kuo
Journal:  Int Neurourol J       Date:  2016-11-22       Impact factor: 2.835

8.  Increased Risk of Stroke in Patients With Fibromyalgia: A Population-BASED Cohort Study.

Authors:  Chun-Hung Tseng; Jiunn-Horng Chen; Yu-Chiao Wang; Ming-Chia Lin; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

9.  Predictive Factors for a Satisfactory Treatment Outcome with Intravesical Botulinum Toxin A Injection in Patients with Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  Hsiu-Jen Wang; Wan-Ru Yu; Hueih-Ling Ong; Hann-Chorng Kuo
Journal:  Toxins (Basel)       Date:  2019-11-19       Impact factor: 4.546

10.  Evaluation of the efficacy of Chinese herbal medicine and acupuncture for the prevention of mental disorders in interstitial cystitis patients: A nationwide population-based study.

Authors:  Hao-Hsiu Hung; Wen-Chi Chen; Yung-Hsiang Chen; Lu-Ting Chiu; Huey-Yi Chen
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.